Hysingla ER and Insulin Glargine (U-100) Cartridge Systems and Pens
Determining the interaction of Hysingla ER and Insulin Glargine (U-100) Cartridge Systems and Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: n.a.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hysingla ER-Insulin Glargine (U-100) Vials
- Hysingla ER-Insulin Glargine (U-300) Pens
- Hysingla ER-Insulin glargine and lixisenatide
- Hysingla ER-Insulin glargine and lixisenatide Subcutaneous
- Hysingla ER-Insulin glargine, recombinant Subcutaneous
- Hysingla ER-Insulin glulisine
- Insulin Glargine (U-100) Cartridge Systems and Pens-Hyskon high molecular weight
- Insulin Glargine (U-100) Cartridge Systems and Pens-Hytone
- Insulin Glargine (U-100) Cartridge Systems and Pens-Hytrin
- Insulin Glargine (U-100) Cartridge Systems and Pens-Hytrin capsules
- Insulin Glargine (U-100) Cartridge Systems and Pens-Hyzaar
- Insulin Glargine (U-100) Cartridge Systems and Pens-Hyzine